Mirae Asset Global Investments’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
CWG
PAM
BC
Mirae Asset Global Investments's NVCR Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its NovoCure (NVCR) stake by 13% in Q2 2026, selling an estimated $11.4K and leaving 5,180 shares worth $78.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.
Mirae Asset Global Investments first reported a position in NVCR in Q4 2019 and has held it in 15 quarters since. The position peaked at $819K in Q2 2021. 76 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- Mirae Asset Global Investments held 5,180 shares of NovoCure worth $78.5K as of Q2 2026.
- Mirae Asset Global Investments sold 755 NovoCure shares in Q2 2026, an estimated $11.4K.
- NovoCure made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1291 holding.
- Mirae Asset Global Investments first reported a position in NovoCure in Q4 2019 and has held it in 15 quarters since.
- Mirae Asset Global Investments's NovoCure position peaked at $819K in Q2 2021.
- 76 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.